Process for determining target function and identifying drug leads

Details for Australian Patent Application No. 2003299518 (hide)

Owner SLANETZ, Alfred, E.

Inventors Not given

Agent Cullens

Pub. Number AU-A-2003299518

PCT Number PCT/US2003/0158

PCT Pub. Number WO2004/037848

Priority 60/381,607 17.05.02 US; 60/381,607 17.05.02 US

Filing date 19 May 2003

Wipo publication date 13 May 2004

Event Publications

27 May 2004 Complete Application Filed

  Priority application(s): 60/381,607 17.05.02 US; 60/381,607 17.05.02 US

1 July 2004 Application Open to Public Inspection

  Published as AU-A-2003299518

2 November 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003299519-HEPATITIS C VIRUS INHIBITORS

2003299517-Mitotic kinesin inhibitors